COVID-CLIMATE: COVID-19: The role of CLinical and IMAging TEsts
- Funded by Netherlands Organisation for Health Research and Development (ZonMW)
- Total publications:0 publications
Grant number: 1.04301E+13
Grant search
Key facts
Disease
COVID-19Start & end year
20212023Funder
Netherlands Organisation for Health Research and Development (ZonMW)Principal Investigator
dr. HA van Piggelen - GietemaResearch Location
NetherlandsLead Research Institution
Maastricht UniversityResearch Priority Alignment
N/A
Research Category
Clinical characterisation and management
Research Subcategory
Supportive care, processes of care and management
Special Interest Tags
N/A
Study Type
Clinical
Clinical Trial Details
Unspecified
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified
Abstract
In the early days of the pandemic, patients were treated with oxygen or ventilation. Medications were also tried with varying results. Some medications have proven to be effective, but it is still unclear to whom these medications are best given. During this period, many CT scans were made to make the diagnosis, because there were few PCR tests. However, these scans also provide information about the severity of the disease and possibly its progression. This project investigates whether the scans can be used to predict better who will need the medicines. Goal Determine whether CT scans can be used to predict which COVID-19 patients will need medication. Research design Some patients continue to have complaints after recovery. The researchers try to predict for each person how this will proceed. To do this, they use CT scans and other information about the health of former patients. In some patients they will make a new type of scan a few months after recovery. This allows them to see whether the permanent abnormalities are caused by inflammation or early scarring.